These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 23861080)

  • 21. Rethinking the Three Rs: Growing Momentum Toward a New Gold Standard in Australian Research.
    Anderson N; Smith R
    Altern Lab Anim; 2024 Jul; 52(4):224-231. PubMed ID: 39115915
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alternatives to animal testing: research, trends, validation, regulatory acceptance.
    Huggins J
    ALTEX; 2003; 20(Suppl 1):3-61. PubMed ID: 14671702
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Futuristic approach to alternatives.
    Akbarsha MA; Majumder A; Misra N; Pellevoisin C; Cotovio J
    ALTEX; 2016; 33(4):469-470. PubMed ID: 27806181
    [No Abstract]   [Full Text] [Related]  

  • 24. Refusal to renew an expiring protocol.
    Lab Anim (NY); 2010 Nov; 39(11):335. PubMed ID: 20962755
    [No Abstract]   [Full Text] [Related]  

  • 25. Which protocol deviations require preapproval?
    Silverman J
    Lab Anim (NY); 2008 Jun; 37(6):243. PubMed ID: 18496538
    [No Abstract]   [Full Text] [Related]  

  • 26. Regulatory acceptance and use of 3R models: a multilevel perspective.
    Schiffelers MJ; Blaauboer BJ; Hendriksen CF; Bakker WE
    ALTEX; 2012; 29(3):287-300. PubMed ID: 22847256
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alternatives initiative in Sri Lanka: pre- and post-conference workshops at the Inaugural Scientific Conference of the Sri Lanka Association for Laboratory Animal Science.
    Gunatilake M; Busquet F; Akbarsha MA
    ALTEX; 2014; 31(2):224-6. PubMed ID: 24794007
    [No Abstract]   [Full Text] [Related]  

  • 28. Working in partnership to advance the 3Rs in toxicity testing.
    Holmes AM; Creton S; Chapman K
    Toxicology; 2010 Jan; 267(1-3):14-9. PubMed ID: 19903508
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Animal Testing Ban Not for EU.
    Optom Vis Sci; 2015 Aug; 92(8):e195-6. PubMed ID: 26421337
    [No Abstract]   [Full Text] [Related]  

  • 30. The '3Rs' model and the concept of alternatives in animal research: a questionnaire survey.
    Pollo S; Vitale A; Gayle V; Zucco F
    Lab Anim (NY); 2004; 33(7):47-53. PubMed ID: 15224118
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Why laboratory rats are here to stay.
    Botham P; Purchase I
    New Sci; 1992 May; 134(1819):29-30. PubMed ID: 11659493
    [No Abstract]   [Full Text] [Related]  

  • 32. Response to refusal to renew an expiring protocol: cruel to be kind.
    Pohl AD; Wallace RG
    Lab Anim (NY); 2010 Nov; 39(11):335-6. PubMed ID: 20962754
    [No Abstract]   [Full Text] [Related]  

  • 33. Which protocol deviations require preapproval? Communication is the key.
    Baskin CR; DeNardo D
    Lab Anim (NY); 2008 Jun; 37(6):243-4. PubMed ID: 18496537
    [No Abstract]   [Full Text] [Related]  

  • 34. The costs of REACH. REACH is largely welcomed, but the requirement to test existing chemicals for adverse effects is not good news for all.
    Breithaupt H
    EMBO Rep; 2006 Oct; 7(10):968-71. PubMed ID: 17016452
    [No Abstract]   [Full Text] [Related]  

  • 35. Defending the use of animals to research human disease.
    Senior K
    Mol Med Today; 1995 Aug; 1(5):220-5. PubMed ID: 17607883
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Which protocol deviations require preapproval? IACUC should develop policies.
    Garcia K; Purcell J
    Lab Anim (NY); 2008 Jun; 37(6):244-5. PubMed ID: 18496539
    [No Abstract]   [Full Text] [Related]  

  • 37. Number of animals used for experimental purposes lower in the European Union.
    von Aulock S
    ALTEX; 2014; 31(1):1. PubMed ID: 24600696
    [No Abstract]   [Full Text] [Related]  

  • 38. Alternatives to animal experimentation: developing in-vitro methods and changing legislation.
    Zbinden G
    Trends Pharmacol Sci; 1990 Mar; 11(3):104-7. PubMed ID: 2104461
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Which protocol deviations require preapproval? Is the deviation significant?
    Fessaha N
    Lab Anim (NY); 2008 Jun; 37(6):244. PubMed ID: 18496540
    [No Abstract]   [Full Text] [Related]  

  • 40. Response to refusal to renew an expiring protocol: a word from OLAW.
    Brown P
    Lab Anim (NY); 2010 Nov; 39(11):337. PubMed ID: 20962758
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.